| |
| |
|
| Insider
Information: |
Arrow Alexander K. |
| Relationship: |
Chief Financial Officer |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
156,202 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,837 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
156,202 |
|
|
| Total
Value |
$7,837 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biolase Inc |
BIOL |
President and COO |
2014-07-22 |
110,387 |
2010-11-10 |
0 |
Premium* |
|
|
Protagenic Therapeutics Ord Shs |
PTIX |
Chief Financial Officer |
2023-10-12 |
45,815 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTIX |
Protagenic Therapeutics O... |
Chief Financial Officer |
• – – |
2023-10-12 |
4 |
B |
$0.81 |
$6,480 |
D/D |
8,000 |
45,815 |
2.74 |
- |
|
| PTIX |
Protagenic Therapeutics O... |
Chief Financial Officer |
• – – |
2022-05-18 |
4 |
B |
$0.72 |
$5,760 |
D/D |
8,000 |
151,260 |
2.74 |
- |
|
| PTIX |
Protagenic Therapeutics O... |
Chief Financial Officer |
• – – |
2022-05-17 |
4 |
B |
$0.71 |
$16,330 |
D/D |
23,000 |
143,260 |
2.74 |
- |
|
| PTIX |
Protagenic Therapeutics O... |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
B |
$2.29 |
$2,290 |
D/D |
1,000 |
120,260 |
2.66 |
- |
|
| PTIX |
Protagenic Therapeutics O... |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
B |
$2.29 |
$2,290 |
D/D |
1,000 |
119,260 |
2.66 |
- |
|
| PTIX |
Protagenic Therapeutics O... |
Chief Financial OfficerOfficer |
• – – |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| BIOL |
Biolase Inc |
President and COO |
• – – |
2014-07-22 |
4 |
B |
$1.92 |
$14,999 |
D/D |
7,812 |
110,387 |
2.74 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2012-08-14 |
4 |
B |
$1.67 |
$16,910 |
D/D |
10,000 |
102,575 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2012-08-13 |
4 |
B |
$1.71 |
$65,791 |
D/D |
37,000 |
92,575 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2012-06-01 |
4 |
B |
$2.33 |
$11,286 |
D/D |
4,800 |
55,575 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2012-05-15 |
4 |
A |
$2.41 |
$4,820 |
D/D |
2,000 |
50,775 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-08-18 |
4 |
B |
$2.84 |
$14,200 |
D/D |
5,000 |
48,775 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-08-17 |
4 |
B |
$2.85 |
$7,980 |
D/D |
2,800 |
43,500 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-08-16 |
4 |
B |
$2.97 |
$14,850 |
D/D |
5,000 |
40,700 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-08-15 |
4 |
B |
$3.05 |
$34,560 |
D/D |
11,200 |
35,700 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-05-31 |
4 |
OE |
$1.15 |
$11,500 |
D/D |
10,000 |
24,500 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-05-26 |
4 |
B |
$4.99 |
$2,495 |
D/D |
500 |
14,500 |
2.31 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-05-20 |
4 |
B |
$4.96 |
$7,440 |
D/D |
1,500 |
14,000 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-05-13 |
4 |
B |
$4.19 |
$4,190 |
D/D |
1,000 |
12,500 |
2.31 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-05-11 |
4 |
B |
$4.62 |
$21,310 |
D/D |
4,500 |
11,500 |
2.39 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2011-04-06 |
4 |
OE |
$1.15 |
$4,600 |
D/D |
4,000 |
7,000 |
0 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2010-11-17 |
4 |
B |
$1.51 |
$1,510 |
D/D |
1,000 |
3,000 |
2.31 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2010-11-16 |
4 |
B |
$1.64 |
$1,640 |
D/D |
1,000 |
2,000 |
2.31 |
- |
|
| BIOL |
Biolase Inc |
Director |
– • – |
2010-11-10 |
4 |
B |
$1.88 |
$1,880 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
